Browse All Treatments

Showing 1856 records.


Page 2 of 186 1 2 3 4 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
1169.8 monthsWaldenstrom macroglobulinemia, marginal zone lymphoma,lymphoplasmacytic lymphoma5ChemotherapyUPMC Université ParisFranceJan 2013
Treatment Details: Patients: This study involved 207 patients with untreated Waldenstrom macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma. The median patient age was 67.8 ye... read more
1267.0 monthsFallopian tube or primary peritoneal cancer4ChemotherapyMemorial Sloan-Kettering Cancer CenterUnited StatesJun 2012
Treatment Details: Patients: This study involved 102 female ovarian, fallopian tube, and primary peritoneal cancer patients. The median patient age was 57 years. Treatment: Patients were treate... read more
1365.3 monthsStage IIB, IIC, and III melanoma5ImmunotherapyUniversity General Hospital AttikonGreeceFeb 2009
Treatment Details: Patients: This phase 3 study involved 353 patients with stage IIB, IIC or III melanoma. These patients had all been treated with surgery (resection). They ranged in age from 19 ... read more
1465.0 monthsAdvanced Epithelial Ovarian Cancer4ChemotherapyOspedale San GerardoItalyFeb 2008
Treatment Details: Patients: This phase II study involved two hundred and eight women with advanced epithelial ovarian cancer. The median age was 52, ranging from 24-73 years old. Treatment: Pa... read more
1563.7 monthsResectable metastases of colorectal carcinoma to the liver5Chemotherapy, SurgeryQueens Hospital CenterUnited StatesMar 2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in ... read more
1663.7 monthsResectable metastatic colorectal carcinoma to the liver5Chemotherapy, SurgeryQueens Hospital CenterUnited StatesMar 2002
Treatment Details: Patients: This trial involved patients with one to three potentially resectable metastases of colorectal carcinoma to the liver. There were a total of 75 “assessable” patients in ... read more
1762.8 monthsAdvanced ovarian cancer5Chemotherapy, ImmunotherapyStädtisches KlinikumGermanySep 2007
Treatment Details: Patients: This phase III study involved one hundred forty-nine women with previously untreated ovarian cancer. All were between the ages of 18 and 65. Treatment: The women r... read more
1861.1 monthsOvarian cancer5ChemotherapyIstituto Nazionale TumoriItalySep 2011
Treatment Details: Patients: This phase II study involved patients with stage IC to IV ovarian cancer not previously treated with chemotherapy who were separated into two different treatment groups.... read more
1960.8 monthsLow-grade NHL4Chemotherapy, ImmunotherapyFox Chase Cancer CenterUnited StatesDec 2004
Treatment Details: Patients: This phase II study involved 31 patients with low-grade non-Hodgkin's lymphoma. The median patient age was 62 years and 15 were male. Treatment: Patients were treat... read more
2059.8 monthsIndolent NHL5Radiation, Biologic therapyCentre Hospitalier de l'Université de MontréalCanadaApr 2014
Treatment Details: Patients: This study involved 93 indolent non-Hodgkin lymphoma patients who had received prior rituximab-based biologic therapy. The median patient age was 59 years and 53.8% wer... read more
Page 2 of 186 1 2 3 4 186